Oroxylin A, but Not Vasopressin, Ameliorates Cardiac Dysfunction of Endotoxemic Rats

The mortality in septic patients with myocardial dysfunction is higher than those without it. Beneficial effects of flavonoid oroxylin A (Oro-A) on endotoxemic hearts were evaluated and compared with that of arginine vasopressin (AVP) which is used to reverse hypotension in septic patients. Endotoxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chin-Hung, Chen, Mei-Fang, Tseng, Tzu-Ling, Chen, Lih-Geeng, Kuo, Jon-Son, Lee, Tony Jer-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489109/
https://www.ncbi.nlm.nih.gov/pubmed/23193421
http://dx.doi.org/10.1155/2012/408187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489109/
https://www.ncbi.nlm.nih.gov/pubmed/23193421
http://dx.doi.org/10.1155/2012/408187

Ejemplares similares